Estrella Immunopharma ESLA
NASDAQ ESLA
$0.65 +0.10 (+18.81%)
As of: Oct 22, 2026 · 11:40 AM EDT

Estrella Immunopharma (ESLA) Other Non-Current Liabilities (2023 - 2026)

Updated

Estrella Immunopharma's Other Non-Current Liabilities came in at $687,224 for Q2 2026, up 47.7% from the prior quarter.

Analysis

Estrella Immunopharma (ESLA) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2025, Estrella Immunopharma's Other Non-Current Liabilities was $356,505, up 12.0% from FY2024.

  • Going back by year, Other Non-Current Liabilities was $318,316 in FY2024 and $12,725 in FY2023.
  • Business Quant data shows ESLA's Other Non-Current Liabilities at $465,132 (Q1 2026), $356,505 (Q4 2025) and $385,355 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn
10 Estrella Immunopharma 28.50 Mn 23.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 687,224.00
Mar 31, 2026 465,132.00
Dec 31, 2025 356,505.00
Sep 30, 2025 385,355.00
Jun 30, 2025 187,941.00
Dec 31, 2024 318,316.00
Jun 30, 2023 12,725.00
API Access

Estrella Immunopharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ESLA&period=max&api_key=YOUR_API_KEY